Clinical trials
Completed Ovarian Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,447 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 29 |
| 2001 | 33 |
| 2002 | 34 |
| 2003 | 44 |
| 2004 | 46 |
| 2005 | 54 |
| 2006 | 60 |
| 2007 | 68 |
| 2008 | 63 |
| 2009 | 58 |
| 2010 | 64 |
| 2011 | 64 |
| 2012 | 50 |
| 2013 | 58 |
| 2014 | 62 |
| 2015 | 72 |
| 2016 | 66 |
| 2017 | 81 |
| 2018 | 78 |
| 2019 | 54 |
| 2020 | 49 |
| 2021 | 49 |
| 2022 | 32 |
| 2023 | 29 |
| 2024 | 15 |
| 2025 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,447 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 74 |
| Memorial Sloan Kettering Cancer Center | 60 |
| Gynecologic Oncology Group | 44 |
| AstraZeneca | 36 |
| M.D. Anderson Cancer Center | 26 |
| Dana-Farber Cancer Institute | 18 |
| ARCAGY/ GINECO GROUP | 17 |
| Eli Lilly and Company | 17 |
| Hoffmann-La Roche | 16 |
| AGO Study Group | 14 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Ovarian Neoplasms | 1,447 |
| Fallopian Tube Neoplasms | 335 |
| Breast Neoplasms | 287 |
| Carcinoma, Ovarian Epithelial | 250 |
| Neoplasms | 147 |
| Endometrial Neoplasms | 136 |
| Uterine Cervical Neoplasms | 127 |
| Colorectal Neoplasms | 124 |
| Carcinoma, Non-Small-Cell Lung | 121 |
| Lung Neoplasms | 115 |
Trials
Showing 1 to 25 of 1,447. Each trial links to its page on Pharma Observatory.
1,347 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.